167 related articles for article (PubMed ID: 12218229)
1. Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities.
Grussendorf-Conen EI; Jacobs S; Rübben A; Dethlefsen U
Dermatology; 2002; 205(2):139-45. PubMed ID: 12218229
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children.
Grussendorf-Conen EI; Jacobs S
Pediatr Dermatol; 2002; 19(3):263-6. PubMed ID: 12047649
[TBL] [Abstract][Full Text] [Related]
3. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
4. Treatment of flat warts with 5% imiquimod cream.
Kim MB; Ko HC; Jang HS; Oh CK; Kwon KS
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1349-50. PubMed ID: 17062069
[No Abstract] [Full Text] [Related]
5. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.
Harwood CA; Perrett CM; Brown VL; Leigh IM; McGregor JM; Proby CM
Br J Dermatol; 2005 Jan; 152(1):122-9. PubMed ID: 15656812
[TBL] [Abstract][Full Text] [Related]
7. Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
Zeng Y; Zheng YQ; Wang L
J Cosmet Laser Ther; 2014 Dec; 16(6):311-3. PubMed ID: 25148409
[TBL] [Abstract][Full Text] [Related]
8. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
Hoyme UB; Hagedorn M; Schindler AE; Schneede P; Hopfenmüller W; Schorn K; Eul A
Infect Dis Obstet Gynecol; 2002; 10(2):79-88. PubMed ID: 12530484
[TBL] [Abstract][Full Text] [Related]
9. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
[TBL] [Abstract][Full Text] [Related]
10. Topical imiquimod for recalcitrant facial flat warts.
Schwab RA; Elston DM
Cutis; 2000 Mar; 65(3):160-2. PubMed ID: 10738635
[TBL] [Abstract][Full Text] [Related]
11. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum.
Hengge UR; Esser S; Schultewolter T; Behrendt C; Meyer T; Stockfleth E; Goos M
Br J Dermatol; 2000 Nov; 143(5):1026-31. PubMed ID: 11069514
[TBL] [Abstract][Full Text] [Related]
12. Plantar warts treated with an immune response modifier: a report of two cases.
Zamiri M; Gupta G
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():45-7. PubMed ID: 14616815
[TBL] [Abstract][Full Text] [Related]
13. Intralesional injection of Mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts: a randomized clinical trial.
Kumar P; Dar L; Saldiwal S; Varma S; Datt Upadhyay A; Talwar D; Sharma VK; Verma KK; Dwivedi SN; Raj R; Gupta S
JAMA Dermatol; 2014 Oct; 150(10):1072-8. PubMed ID: 25103148
[TBL] [Abstract][Full Text] [Related]
14. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
Gilson RJ; Shupack JL; Friedman-Kien AE; Conant MA; Weber JN; Nayagam AT; Swann RV; Pietig DC; Smith MH; Owens ML
AIDS; 1999 Dec; 13(17):2397-404. PubMed ID: 10597781
[TBL] [Abstract][Full Text] [Related]
16. Topical treatment of common warts in an HIV-positive patient with imiquimod 5% cream.
Juschka U; Hartmann M
Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():48-50. PubMed ID: 14616816
[TBL] [Abstract][Full Text] [Related]
17. 5% topical imiquimod tolerance in transplant recipients.
Ben M'barek L; Mebazaa A; Euvrard S; Frances C; Thervet E; Morel P; Menasché S; Legendre C; Lebbe C
Dermatology; 2007; 215(2):130-3. PubMed ID: 17684375
[TBL] [Abstract][Full Text] [Related]
18. Treatment of non-genital warts with topical imiquimod 5% cream.
Muzio G; Massone C; Rebora A
Eur J Dermatol; 2002; 12(4):347-9. PubMed ID: 12095879
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod in the treatment of cutaneous warts: an evidence-based review.
Ahn CS; Huang WW
Am J Clin Dermatol; 2014 Oct; 15(5):387-99. PubMed ID: 25186654
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
Vexiau D; Decuypère L; Moyse D; Aractingi S
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):845-51. PubMed ID: 16327713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
